PD-L1 aptamer-functionalized degradable hafnium oxide nanoparticles for near infrared-II diagnostic imaging and radiosensitization.

Wei, Min; Shen, Xiao; Fan, Xueqi; Li, Jiwei; Bai, Jingwen

Wei, Min; Shen, Xiao; Fan, Xueqi; Li, Jiwei; Bai, Jingwen.

Afiliação

Wei M; Cancer Center and Department of Breast and Thyroid Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Shen X; Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Fan X; Xiamen Key Laboratory of Endocrine-Related Cancer Precision Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Li J; Xiamen Research Center of Clinical Medicine in Breast and Thyroid Cancers, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Bai J; Cancer Research Center of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

Front Bioeng Biotechnol ; 11: 1224339, 2023.

Article em En | MEDLINE | ID: mdl-37351473

Palavras-chave

NIR-II fluorescence imaging; PD-L1 aptamer; checkpoint blockade immunotherapy; radiation therapy; tumor treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 15_ODS3_global_health_risks Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google